Literature DB >> 10438490

Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor.

S Silvente-Poirot1, C Escrieut, C Galès, J A Fehrentz, A Escherich, S A Wank, J Martinez, L Moroder, B Maigret, M Bouisson, N Vaysse, D Fourmy.   

Abstract

Recently, we reported that the mutation of His(207) to Phe located in the second extracellular loop of the cholecystokinin B receptor strongly affected cholecystokinin (CCK) binding (Silvente-Poirot, S., Escrieut, C., and Wank, S. A. (1998) Mol. Pharmacol. 54, 364-371). To characterize the functional group in CCK that interacts with His(207), we first substituted His(207) to Ala. This mutation decreased the affinity and the potency of CCK to produce total inositol phosphates 302-fold and 456-fold without affecting the expression of the mutant receptor. The screening of L-alanine-modified CCK peptides to bind and activate the wild type and mutant receptors allowed the identification of the interaction of the C-terminal Asp(8) of CCK with His(207). The H207A-CCKBR mutant, unlike the wild type receptor, was insensitive to substitution of Asp(8) of CCK to other amino acid residues. This interaction was further confirmed by mutating His(207) to Asp. The affinity of CCK for the H207D-CCKBR mutant was 100-fold lower than for the H207A-CCKBR mutant, consistent with an electrostatic repulsion between the negative charges of the two interacting aspartic acids. Peptides with neutral amino acids in position eight of CCK reversed this effect and displayed a gain of affinity for the H207D mutant compared with CCK. To date, this is the first report concerning the identification of a direct contact point between the CCKB receptor and CCK.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438490     DOI: 10.1074/jbc.274.33.23191

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.

Authors:  V Gigoux; B Maigret; C Escrieut; S Silvente-Poirot; M Bouisson; J A Fehrentz; L Moroder; D Gully; J Martinez; N Vaysse; A D Fourmy
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Role of AMP-18 in oral mucositis.

Authors:  Peili Chen; Mark Lingen; Stephen T Sonis; Margaret M Walsh-Reitz; F Gary Toback
Journal:  Oral Oncol       Date:  2011-07-06       Impact factor: 5.337

3.  Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor.

Authors:  Nieves González; Tomoo Nakagawa; Samuel A Mantey; Veronica Sancho; Hirotsugu Uehara; Tatsuro Katsuno; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2009-07-23       Impact factor: 4.030

Review 4.  Structural basis of cholecystokinin receptor binding and regulation.

Authors:  Laurence J Miller; Fan Gao
Journal:  Pharmacol Ther       Date:  2008-05-11       Impact factor: 12.310

5.  Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor.

Authors:  Piotr F J Lipiński; Piotr Garnuszek; Michał Maurin; Raphael Stoll; Nils Metzler-Nolte; Artur Wodyński; Jan Cz Dobrowolski; Marta K Dudek; Monika Orzełowska; Renata Mikołajczak
Journal:  EJNMMI Res       Date:  2018-04-16       Impact factor: 3.138

6.  Permanent Photodynamic Activation of the Cholecystokinin 2 Receptor.

Authors:  Wen Zhu Tang; Zong Jie Cui
Journal:  Biomolecules       Date:  2020-02-04

7.  Flexibility and extracellular opening determine the interaction between ligands and insect sulfakinin receptors.

Authors:  Na Yu; Moises João Zotti; Freja Scheys; Antônio S K Braz; Pedro H C Penna; Ronald J Nachman; Guy Smagghe
Journal:  Sci Rep       Date:  2015-08-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.